Cargando…
Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond
Many assays to evaluate the nature, breadth, and quality of antigen-specific T cell responses are currently applied in human medicine. In most cases, assay-related protocols are developed on an individual laboratory basis, resulting in a large number of different protocols being applied worldwide. T...
Autores principales: | Britten, C. M., Janetzki, S., van der Burg, S. H., Huber, C., Kalos, M., Levitsky, H. I., Maecker, H. T., Melief, C. J. M., O’Donnell-Tormey, J., Odunsi, K., Old, L. J., Pawelec, G., Roep, B. O., Romero, P., Hoos, A., Davis, M. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029829/ https://www.ncbi.nlm.nih.gov/pubmed/21080166 http://dx.doi.org/10.1007/s00262-010-0940-z |
Ejemplares similares
-
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
por: Britten, Cedrik Michael, et al.
Publicado: (2009) -
Toward the harmonization of immune monitoring in clinical trials: Quo vadis?
por: Britten, C. M., et al.
Publicado: (2007) -
A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
por: Attig, Sebastian, et al.
Publicado: (2011) -
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
por: Janetzki, Sylvia, et al.
Publicado: (2007) -
Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring
por: Hoos, Axel, et al.
Publicado: (2012)